Shopping Cart
- Remove All
- Your shopping cart is currently empty
hMAO-B/MB-COMT-IN-2 is a dual inhibitor of MAO-B/MB-COMT with IC50s of 4.27 μM and 2.69 μM for hMAO-B and MB-COMT, respectively. hMAO-B/MB-COMT-IN-2 protects cells from oxidative damage and can be used in neurodegeneration disease research, such as Parkinson’s Disease (PD) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 10-14 weeks | |
50 mg | $1,980 | 10-14 weeks | |
100 mg | $2,500 | 10-14 weeks |
Description | hMAO-B/MB-COMT-IN-2 is a dual inhibitor of MAO-B/MB-COMT with IC50s of 4.27 μM and 2.69 μM for hMAO-B and MB-COMT, respectively. hMAO-B/MB-COMT-IN-2 protects cells from oxidative damage and can be used in neurodegeneration disease research, such as Parkinson’s Disease (PD) [1]. |
In vitro | hMAO-B/MB-COMT-IN-2 (compound 8) exerts several effects on differentiated SH-SY5Y cells: at 50 μM over 24 hours, it reduces resazurin reduction and induces lysosomal toxicity via reactive oxygen species (ROS) production; at 10 μM for 30 minutes, it shows significant cytoprotective properties against t-BHP. It crosses the blood-brain barrier (BBB) via passive diffusion, confirmed by the PAMPA-BBB kit. Additionally, it has a good safety profile in SK-N-SH cells at 30-50 μM over 24 hours [1]. |
Molecular Weight | 298.34 |
Formula | C17H18N2O3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.